|
|
||||||||
The Journal of Immunology, Vol 156, Issue 11 4391-4400, Copyright © 1996 by American Association of Immunologists
ARTICLES |
M Hewison, M Dabrowski, S Vadher, L Faulkner, FJ Cockerill, PM Brickell, JL O'Riordan and DR Katz
Department of Medicine, University College London Medical School, The Middlesex Hospital, England.
The active vitamin D3 metabolite 1,25-dihydroxycholecalciferol (1,25(OH)2D3) acts as an antiproliferative and differentiating agent for the monoblastoid cell line U937 and as an important immunologic mediator implicated particularly in the function of cells belonging to the monocyte/macrophage lineage. These effects are controlled by the vitamin D receptor (VDR), a member of the steroid hormone receptor family. The objective of this study was to develop U937 transfectants expressing antisense VDR mRNA, and to use these to examine the role of 1,25(OH)2D3-VDR interaction in this lineage. A 2-kb VDR cDNA insert (including the complete VDR coding region) was cloned in an antisense orientation into the EBV episomal vector pMEP4 under the control of an inducible promoter and transfected into U937. The resultant cell line, DH42, was hygromycin resistant, contained VDR cDNA, expressed fewer VDRs than controls, and showed a substantial decrease in antiproliferative response to 1,25(OH)2D3. However, 1,25(OH)2D3 increased the number of cells expressing macrophage cell surface Ags, including CD14 and CD11b. A subpopulation of smaller cells did not express the differentiation markers after cadmium stimulation. Cell cycle analysis showed shifts in the distribution of cells from G1 to S phase, which were more pronounced after cadmium treatment. A considerable proportion of cells were outside the cycle and DNA fragmentation confirmed apoptosis. Thus, the functional outcome of the VDR antisense transfection suggests that in the myelomonocytic lineage, VDR expression may act as a protective mechanism against programmed cell death.
This article has been cited by other articles:
![]() |
Q.-P. Li, X. Qi, R. Pramanik, N. M. Pohl, M. Loesch, and G. Chen Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity J. Biol. Chem., January 19, 2007; 282(3): 1544 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiizaki, S. Negi, I. Hatamura, T. Sakaguchi, F. Saji, K. Kunimoto, M. Mizobuchi, I. Imazeki, A. Ooshima, and T. Akizawa Biochemical and Cellular Effects of Direct Maxacalcitol Injection into Parathyroid Gland in Uremic Rats J. Am. Soc. Nephrol., January 1, 2005; 16(1): 97 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi, J. Tang, R. Pramanik, R. M. Schultz, S. Shirasawa, T. Sasazuki, J. Han, and G. Chen p38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells through Regulation of Vitamin D Receptor J. Biol. Chem., May 21, 2004; 279(21): 22138 - 22144. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terada, M. Takizawa, S. Yamamoto, O. Ezaki, H. Itakura, and K. S. Akagawa Eicosapentaenoic acid inhibits CSF-induced human monocyte survival and maturation into macrophage through the stimulation of H2O2 production J. Leukoc. Biol., June 1, 2002; 71(6): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grande, M. Montanari, E. Tagliafico, R. Manfredini, T. Z. Marani, M. Siena, E. Tenedini, A. Gallinelli, and S. Ferrari Physiological levels of 1{alpha}, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors J. Leukoc. Biol., April 1, 2002; 71(4): 641 - 651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |